Rapid identification of chemical constituents of Fuzheng Huayu capsules by UHPLC-TOF/MS
-
摘要: 目的 运用超高效液相色谱-高分辨飞行时间质谱(UHPLC-TOF/MS)联用技术鉴别扶正化瘀胶囊中化学成分。 方法 色谱分离采用ACQUITY UPLCHSS T3柱(2.1 mm×100 mm,1.8 μm);流动相0.1%甲酸水溶液(A)-0.1%甲酸乙腈溶液(B),梯度洗脱条件:0~3 min,2% B;3~18 min,2%~50% B;18~22 min,50%~95% B;22~25 min,95% B。平衡时间为10 min,流速为0.4 ml/min,分析时间为25 min。质谱定性采用电喷雾离子源,正/负离子模式扫描,采集范围100~1 100 m/z。 结果 正/负离子模式下,一次性鉴别出154个成分,其中,正、负离子模式下均有响应的有28个。 结论 较全面地阐明了扶正化瘀胶囊的成分组成,为该复方的深入研究奠定了基础。Abstract: Objective To identify the chemical constituents in Fuzheng Huayu capsule by ultra performance liquid chromatography-high resolution time of flight mass spectrometry(UHPLC-TOF/MS). Methods ACQUITY UPLCHSS T3(2.1mm×100mm,1.8μm) was used to chromatographic separation; mobile phase 0.1% formic acid aqueous solution(A) -0.1% formic acid acetonitrile solution(B),gradient elution conditions:0-3min,2% B; 3-18 min,2%-50% B; 18-22 min,50%-95% B; 22-25 min,95% B.The equilibration time was 10 min,the flow rate was 0.40 ml/min,and the analysis time was 25 min.Mass spectrometry was performed by an electrospray ion source using a positive-negative ion mode scan with a range of 100-1 100 m/z. Results 154 components were identified at one time,of which 28 were positive and negative ion modes. Conclusion The composition of Fuzheng Huayu capsule was comprehensively clarified in this study,which laid a foundation for further research of this compound.
-
Key words:
- Fuzheng Huayu capsule /
- identification /
- chemical composition
-
[1] CHEN Q,WU F,WANG M,et al.Transcriptional profiling and miRNA-target network analysis identify potential biomarkers for efficacy evaluation of Fuzheng-Huayu formula-treated hepatitis b caused liver cirrhosis[J].Int J Mol Sci,2016,17(6):883. [2] CHENG Q,LI N,CHEN M,et al.Fuzheng Huayu inhibits carbon tetrachloride-induced liver fibrosis in mice through activating hepatic NK cells[J].J Ethnopharmacol,2013,145(1):175-181. [3] LIU P.Fuzheng huayu capsule in the treatment of liver fibrosis:clinical evidence and mechanism of action[J].Chin J Integr Med,2012,18(5):398-400. [4] LIU P,LIU C,XU L M,et al.Effects of Fuzheng Huayu 319 recipe on liver fibrosis in chronic hepatitis B[J].World J Gastroenterol,1998,4(4):348-353. [5] TAO Y Y,YAN X C,ZHOU T,et al.Fuzheng Huayu recipe alleviates hepatic fibrosis via inhibiting TNF-alpha induced hepatocyte apoptosis[J].BMC Compl Altern Med,2014,14,449. [6] WANG R Q,MI H M,LI H,et al.Modulation of IKKbeta/NF-kappaB and TGF-beta1/Smad via Fuzheng Huayu recipe involves in prevention of nutritional steatohepatitis and fibrosis in mice[J].Iran J Basic Med Sci,2015,18(4):404-411. [7] XIE H,TAO Y,LV J,et al.Proteomic analysis of the effect of fuzheng huayu recipe on fibrotic liver in rats[J].Evid Based Compl Alternat Med,2013,2013,972863. [8] XING X,CHEN S,LI L,et al.The active components of Fuzheng Huayu Formula and their potential mechanism of action in inhibiting the hepatic stellate cells viabilitya network pharmacology and transcriptomics approach[J].Front Pharmacol,2018,9,525. [9] 陈珏蓓,马文彪,王月红.HPLC法测定心舒乐片中丹参酮ⅡA、羟基红花黄色素A、苦杏仁苷[J].中成药,2012,34(3):490-494. [10] 范小云,吴青芸.扶正化瘀胶囊治疗慢性乙型肝炎肝纤维化60例疗效分析[J].中国医药指南,2012,10(18):272-273. [11] 官玲花.HPLC法同时测定仙灵骨葆胶囊中二氢丹参酮Ⅰ、隐丹参酮、丹参酮Ⅰ和丹参酮Ⅱ_A的含量[J].中国药房,2013,24(32):3056-3058. [12] 马琳,黄小方,欧阳辉.UHPLC/Q-TOF-MS/MS快速鉴定陈皮化学成分[J].亚太传统医药,2015,11(19):33-37. [13] 夏爱军,李玲,董昕,UHPLC-Q-TOF/MS技术应用于中药旱莲草化学成分研究[J].解放军药学学报,2012,28(5):404-407. [14] 张启云,彭国梅,李冰涛,等.UHPLC-Q-TOF/MS技术分析葛根醇提液中化学成分[J].中药新药与临床药理,2017,28(4):513-518. [15] 张淑瑜.复方汉防己颗粒中丹参酮ⅡA的成分鉴别和含量测定[J].药学实践杂志,2013,31(3):228-230. [16] 赵长青,吴艺青,徐列明.扶正化瘀胶囊抗肝纤维化的临床疗效和作用机制[J].中西医结合学报,2006,4(5):467-472.
计量
- 文章访问数: 2702
- HTML全文浏览量: 243
- PDF下载量: 334
- 被引次数: 0